This review highlights recent advances in STEMI management and emphasizes the anticipated increase in coronary heart disease incidence due to the aging baby boomer population.
Answers are grounded in this paper and cite their sources.
Anticipates rising STEMI burden from aging demographics; leaves open how recent advances will affect population outcomes.
ST elevation myocardial infarction (STEMI) remains a leading cause of morbidity, mortality and disability worldwide. Statistically, a trend towards improvements in morbidity and mortality has been consistent over the years, which is attributed primarily to the modification of risk factors, healthier lifestyles, treatment advances and better management of door-to-balloon times via STEMI systems. However, a major challenge in the coming years will be the baby boomers (born between the years 1946 and 1964) coming into old age. The first baby boomers turned 65 in year 2011. As the baby boomers age in the coming years, the incidence of coronary heart disease is likely to increase, and so there will be a greater need to have major advances in the management of coronary heart disease in order to deal with this additional incidence. The scope of this article is to review recent advances in the management of STEMI and to provide an updated overview.
No takes yet. Share an insight, caveat, or question.
Ganjehei et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: